| Merck (Schweiz) AG - Rebif 8.8 und 22, Injektionslösung in Fertigspritzen | | 54810 | | 04 | | Rebif 8.8 und 22 | | Injektionslösung in Fertigspritzen | | L03AB07 | | Interferon Beta-1a | | 10.10.2008 | | |
| | Composition | | I) 8.8 mcg/0.2 ml: interferonum beta-1a ADNr 8.8 µg corresp. 2.4 Mio U.I., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg.
II) 22 mcg/0.5 ml: interferonum beta-1a ADNr 22 µg corresp. 6 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. | | Packungsbestandteile | | I | | | Injektionslösung in Fertigspritze | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 8.8µg / 0.2ml |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum | | | Alcohol Benzylicus | 1mg / 0.2ml | | Mannitolum | | | Methioninum | | | Natrii Acetas Trihydricum | | | Natrii Hydroxidum | | | Poloxamerum | 188 |
| |
| II | | | Injektionslösung in Fertigspritze | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum | | | Alcohol Benzylicus | 2.5mg / 0.5ml | | Mannitolum | | | Methioninum | | | Natrii Acetas Trihydricum | | | Natrii Hydroxidum | | | Poloxamerum | 188 |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 060 | 6 Kombipackung(en) | 599.44 | 668.35 | B | SL | Yes |
|
|
